1. Home
  2. MESO vs USAS Comparison

MESO vs USAS Comparison

Compare MESO & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

N/A

Current Price

$13.68

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

N/A

Current Price

$2.96

Market Cap

1.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
MESO
USAS
Founded
2004
1998
Country
Australia
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2005
2004

Fundamental Metrics

Financial Performance
Metric
MESO
USAS
Price
$13.68
$2.96
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
★ $37.00
$7.54
AVG Volume (30 Days)
255.3K
★ 3.9M
Earning Date
08-26-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$51.63
$102.27
Revenue Next Year
$63.39
$70.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.89
$2.67
52 Week High
$21.50
$10.50

Technical Indicators

Market Signals
Indicator
MESO
USAS
Relative Strength Index (RSI) 46.52 38.08
Support Level $11.89 $2.67
Resistance Level $16.03 $5.25
Average True Range (ATR) 0.50 0.20
MACD 0.07 0.05
Stochastic Oscillator 40.72 43.92

Price Performance

Historical Comparison
MESO
USAS

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

Share on Social Networks: